Anti-acid therapy in idiopathic pulmonary fibrosis: insights from the INPULSIS® trials

about

Anti-acid therapy in idiopathic pulmonary fibrosis: insights from the INPULSIS® trials

Item

http://www.wikidata.org/entity/Q58768071

description

im September 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Anti-acid therapy in idiopathic pulmonary fibrosis: insights from the INPULSIS® trials

@en

Anti-acid therapy in idiopathic pulmonary fibrosis: insights from the INPULSIS® trials

@nl

type

Item

label

Anti-acid therapy in idiopathic pulmonary fibrosis: insights from the INPULSIS® trials

@en

Anti-acid therapy in idiopathic pulmonary fibrosis: insights from the INPULSIS® trials

@nl

prefLabel

Anti-acid therapy in idiopathic pulmonary fibrosis: insights from the INPULSIS® trials

@en

Anti-acid therapy in idiopathic pulmonary fibrosis: insights from the INPULSIS® trials

@nl

P1476

Anti-acid therapy in idiopathic pulmonary fibrosis: insights from the INPULSIS® trials

@en

P2093

Bruno Crestani

http://www.w3.org/2001/XMLSchema#string

Ganesh Raghu

http://www.w3.org/2001/XMLSchema#string

Jürgen Behr

http://www.w3.org/2001/XMLSchema#string

Rozsa Schlenker-Herceg

http://www.w3.org/2001/XMLSchema#string

Susanne Stowasser

http://www.w3.org/2001/XMLSchema#string

Wibke Stansen

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials.

Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone.

Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.

Acid-suppressive medication use and the risk for hospital-acquired pneumonia.

Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis.

Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry.

Sole treatment of acid gastroesophageal reflux in idiopathic pulmonary fibrosis: a case series.

Idiopathic Pulmonary Fibrosis: Novel Concepts of Proton Pump Inhibitors as Antifibrotic Drugs.

P2888

s12931-018-0866-0

P304

167

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12931-018-0866-0

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ulrich Costabel

P577

2018-09-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1106525535

http://www.w3.org/2001/XMLSchema#string

P698

30176872

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

P932

6122773

http://www.w3.org/2001/XMLSchema#string